124.645 USD
-1.04 (-0.82%)
ChartMill assigns a Buy % Consensus number of 86% to ABVX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 123.46. This target is -0.95% below the current price.
ABVX was analyzed by 14 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about ABVX.
In the previous month the buy percentage consensus was at a similar level.
ABVX was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-24 | Truist Securities | Initiate | Buy |
| 2025-11-06 | Wolfe Research | Initiate | Outperform |
| 2025-10-13 | Barclays | Initiate | Overweight |
| 2025-10-10 | Guggenheim | Maintains | Buy -> Buy |
| 2025-10-07 | BTIG | Maintains | Buy -> Buy |
| 2025-09-25 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-09-12 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-09 | BTIG | Reiterate | Buy -> Buy |
| 2025-07-29 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-23 | LifeSci Capital | Maintains | Outperform -> Outperform |
| 2025-07-23 | Guggenheim | Maintains | Buy -> Buy |
| 2025-07-23 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-07-23 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-04-30 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-18 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-01-10 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-12-04 | JMP Securities | Initiate | Market Outperform |
| 2024-07-29 | Laidlaw & Co. | Initiate | Buy |
| 2024-05-20 | BTIG | Initiate | Buy |
| 2024-04-29 | Guggenheim | Initiate | Buy |
| 2024-04-29 | Piper Sandler | Initiate | Overweight |
| 2024-04-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-11-14 | Leerink Partners | Initiate | Outperform |
| 2023-11-14 | Morgan Stanley | Initiate | Equal-Weight |
ABIVAX SA-ADR / ABVX FAQ
What is the price target for ABVX stock?
14 analysts have analysed ABVX and the average price target is 123.46 USD. This implies a price decrease of -0.95% is expected in the next year compared to the current price of 124.645.
Can you provide the consensus rating for ABIVAX SA-ADR stock?
The consensus rating for ABIVAX SA-ADR (ABVX) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.